Hyperthermic intraperitoneal chemotherapy enhances blood coagulation perioperatively evaluated by thromboelastography: a pilot study

References

• Kapoor S, Bassily-Marcus A, Alba Yunen R, et al. Critical care management and intensive care unit outcomes following cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. WJCCM. 2017;6(2):116–123.
   Google Scholar
• Mehta SS, Gelli M, Agarwal D, et al. Complications of cytoreductive surgery and HIPEC in the treatment of peritoneal metastases. Indian J Surg Oncol. 2016;7(2):225–229.
   PubMed Web of Science ®Google Scholar
• Mohamed F, Moran BJ. Morbidity and mortality with cytoreductive surgery and intraperitoneal chemotherapy: the importance of a learning curve. Cancer J. 2009;15(3):196–199.
   PubMed Web of Science ®Google Scholar
• Wong EYT, Tan GHC, Chia CSL, et al. Morbidity and mortality of elderly patients following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC). Asia Pac J Clin Oncol. 2018;14(2):e193–e202.
   Web of Science ®Google Scholar
• Samama C, Boubli L, Coloby P, et al. Venous thromboembolism prophylaxis in patients undergoing abdominal or pelvic surgery for cancer – a real-world, prospective, observational french study: PRéOBS. Thromb Res. 2014;133(6):985–92.
   Web of Science ®Google Scholar
• McCrath DJ, Cerboni E, Frumento RJ, et al. Thromboelastography maximum amplitude predicts postoperative thrombotic complications including myocardial infarction. Anesth Analg. 2005;100(6):1576–1583.
   PubMed Web of Science ®Google Scholar
• Sugimachi K, Tajiri H, Kinjo N, et al. Incidence and predictors of deep venous thrombosis after abdominal oncologic surgery: prospective doppler ultrasound screening. J Surg Res. 2012;178(2):657–661.
   PubMed Web of Science ®Google Scholar
• Rasmussen MS, Jørgensen LN, Wille-Jørgensen P. Prolonged thromboprophylaxis with low molecular weight heparin for abdominal or pelvic surgery. Cochrane Database Syst Rev. 2009;(1):CD004318.
   PubMed Web of Science ®Google Scholar
• Kakkar VV, Balibrea JL, Martinez-Gonzalez J, et al. On Behalf Of The Canbesure Study Group. Extended prophylaxis with bemiparin for the prevention of venous thromboembolism after abdominal or pelvic surgery for cancer: the CANBESURE randomized study. J Thromb Haemost. 2010;8(6):1223–1229.
   PubMed Web of Science ®Google Scholar
• Vukadinovic V, Chiou JD, Morris DL. Clinical features of pulmonary emboli in patients following cytoreductive surgery (peritonectomy) and hyperthermic intraperitoneal chemotherapy (hipec), a single centre experience. Eur J Surg Oncol. 2015;41(5):702–706.
   PubMed Web of Science ®Google Scholar
• Meyer MAS, Ostrowski SR, Overgaard A, et al. Hypercoagulability in response to elevated body temperature and central hypovolemia. J Surg Res. 2013;185(2):e93–e100.
   PubMed Web of Science ®Google Scholar
• Pivalizza EG, Koch SM, Mehlhorn U, et al. The effects of intentional hyperthermia on the thrombelastograph and the sonoclot analyser. Int J Hyperthermia. 1999;15(3):217–223.
   PubMed Web of Science ®Google Scholar
• Da Luz LT, Nascimento B, Shankarakutty AK, et al. Effect of thromboelastography (TEG(R)) and rotational thromboelastometry (ROTEM(R)). Crit Care. 2014;18(5):518–014.
   PubMed Web of Science ®Google Scholar
• Shore-Lesserson L, Manspeizer HE, DePerio M, et al. Thromboelastography-guided transfusion algorithm reduces transfusions in complex cardiac surgery. Anesth Analg. 1999;88(2):312–319.
   PubMed Web of Science ®Google Scholar
• Westbrook AJ, Olsen J, Bailey M, et al. Protocol based on thromboelastograph (TEG) out-performs physician preference using laboratory coagulation tests to guide blood replacement during and after cardiac surgery: a pilot study. Heart Lung Circ. 2009;18(4):277–288.
   PubMed Web of Science ®Google Scholar
• Kashuk JL, Moore EE, Sabel A, et al. Rapid thrombelastography (r-TEG) identifies hypercoagulability and predicts thromboembolic events in surgical patients. Surgery (USA). 2009;146(4):764–774.
   PubMed Web of Science ®Google Scholar
• Toukh M, Siemens DR, Black A, et al. Thromboelastography identifies hypercoagulablilty and predicts thromboembolic complications in patients with prostate cancer. Thromb Res. 2014;133(1):88–95.
   PubMed Web of Science ®Google Scholar
• Park MS, Martini WZ, Dubick MA, et al. Thromboelastography as a better indicator of hypercoagulable state after injury than prothrombin time or activated partial thromboplastin time. J Trauma Inj Infect Crit Care. 2009;67(2):266–275.
   PubMedGoogle Scholar
• Liu C, Guan Z, Xu Q, et al. Relation of thromboelastography parameters to conventional coagulation tests used to evaluate the hypercoagulable state of aged fracture patients. Medicine (Baltimore). 2016;95(24):e3934.
   PubMed Web of Science ®Google Scholar
• Elias D, Di Pietrantonio D, Boulet T, et al. Natural history” of complete cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. Eur J Surg Oncol. 2009;35(4):434–438.
   PubMed Web of Science ®Google Scholar
• Tuovila M, Erkinaro T, Savolainen ER, et al. The impact of sample site and storage on thromboelastography values. Am J Hematol. 2017;92(8):E160–E162.
   PubMed Web of Science ®Google Scholar
• Vig S, Chitolie A, Bevan DH, et al. Thromboelastography: a reliable test?. Blood Coagul Fibrinolysis. 2001;12(7):555–561.
   PubMed Web of Science ®Google Scholar
• Falcon Arana L, Fuentes-Garcia D, Roca Calvo MJ, et al. Alterations in hemostasis during cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis. Cir Esp. 2015;93(8):496–501.
   PubMed Web of Science ®Google Scholar
• Bell JC, Rylah BG, Chambers RW, et al. Perioperative management of patients undergoing cytoreductive surgery combined with heated intraperitoneal chemotherapy for peritoneal surface malignancy: a multi-institutional experience. Ann Surg Oncol. 2012;19(13):4244–4251.
   PubMed Web of Science ®Google Scholar
• Preti V, Chang D, Sugarbaker PH. Pulmonary complications following cytoreductive surgery and perioperative chemotherapy in 147 consecutive patients. Gastroenterol Res Pract. 2012;2012:1–8.
   Web of Science ®Google Scholar
• Sargant N, Roy A, Simpson S, et al. A protocol for management of blood loss in surgical treatment of peritoneal malignancy by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Transfusion Med. 2016;26(2):118–122.
   PubMed Web of Science ®Google Scholar
• Schmidt C, Creutzenberg M, Piso P, et al. Peri-operative anaesthetic management of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. Anaesthesia. 2008;63(4):389–395.
   PubMed Web of Science ®Google Scholar
• Mahla E, Lang T, Vicenzi MN, et al. Thromboelastography for monitoring prolonged hypercoagulability after major abdominal surgery. Anesth Analg. 2001;92(3):572–577.
   PubMed Web of Science ®Google Scholar
• Thorson CM, Van Haren RM, Ryan ML, et al. Pre-existing hypercoagulability in patients undergoing potentially curative cancer resection. Surgery. 2014;155(1):134–144.
   PubMed Web of Science ®Google Scholar
• Ziegler S, Ortu A, Reale C, et al. Fibrinolysis or hypercoagulation during radical prostatectomy? an evaluation of thrombelastographic parameters and standard laboratory tests. Eur J Anaesthesiol. 2008;25(7):538–543.
   PubMed Web of Science ®Google Scholar
• Nagaya S, Wada H, Oka K, et al. Hemostatic abnormalities and increased vascular endothelial cell markers in patients with red cell fragmentation syndrome induced by mitomycin C. Am J Hematol. 1995;50(4):237–243.
   PubMed Web of Science ®Google Scholar
• Paar M, Rossmann C, Nusshold C, et al. Anticoagulant action of low, physiologic, and high albumin levels in whole blood. PLoS One. 2017;12(8):e0182997.
   PubMed Web of Science ®Google Scholar
• Hammad Y, Elmoghazy W, El Ansari W, et al. Experimental effect of different dilutions of blood with human plasma protein fraction and large dose factor one on blood coagulation and chemistry in vitro. Indian J Anaesth. 2019;63(12):1015–1021.
   PubMed Web of Science ®Google Scholar
• Rasmussen KC, Hojskov M, Johansson PI, et al. Impact of albumin on coagulation competence and hemorrhage during major surgery: a randomized controlled trial. Medicine (Baltimore). 2016;95(9):e2720.
   PubMed Web of Science ®Google Scholar
• Coccolini F, Corbella D, Finazzi P, et al. Time course of cytokines, hemodynamic and metabolic parameters during hyperthermic intraperitoneal chemotherapy. Minerva Anestesiol. 2016;82(3):310–319.
   PubMed Web of Science ®Google Scholar
• Jezovnik MK, Fareed J, Poredos P. Patients with a history of idiopathic deep venous thrombosis have long-term increased levels of inflammatory markers and markers of endothelial damage. Clin Appl Thromb Hemost. 2017;23(2):124–131.
   PubMed Web of Science ®Google Scholar
• Vazquez-Garza E, Jerjes-Sanchez C, Navarrete A, et al. Venous thromboembolism: thrombosis, inflammation, and immunothrombosis for clinicians. J Thromb Thrombolysis. 2017;44(3):377–385.
   PubMed Web of Science ®Google Scholar